+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Three-day treatment with butoconazole vaginal suppositories for vulvovaginal candidiasis



Three-day treatment with butoconazole vaginal suppositories for vulvovaginal candidiasis



Journal of Reproductive Medicine 31(2): 131-132



Butoconazole is a new imidazole, effective as therapy for vulvovaginal candidiasis for women who prefer solid-type vaginal preparations. The efficacy of three-day administration of butoconazole vaginal suppositories, 100 mg/day, was compared to that of clotrimazole vaginal tablets, 200 mg/day. Patients with culture-proven vulvovaginal candidiasis were randomly assigned to either butoconazole (97 patients) or clotrimazole (88 patients). The percentage of patients with fungal cultures negative for Candida albicans was statistically significantly higher for butoconazole than for clotrimazole (92 vs. 74, P = .003) at the eight-day posttreatment examination. At the 30-day posttreatment examination the cure rate was still higher for butoconazole (63%) than for clotrimazole (56%), but the difference was not statistically significant. Complete clinical relief was achieved in 81% of patients in both treatment groups achieved in 81% of patients in both treatment groups at the first follow-up examination, while at the second follow-up examination the clinical cure rate was 77% for butoconazole and 69% for clotrimazole. No systemic side effects were reported.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041802360

Download citation: RISBibTeXText

PMID: 3514908


Related references

Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placebo. Journal of Reproductive Medicine 31(11): 1045-1048, 1986

Butoconazole vaginal inserts for vulvovaginal candidiasis comparison of clotrimazole. Advances in Therapy 2(2): 60-64, 1985

The statement of Polish Gynecological Society Experts on the treatment of acute vulvovaginal candidiasis with prolonged releasing 2% butoconazole nitrate vaginal cream--state of art in 2008. Ginekologia Polska 80(4): 303-311, 2009

Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group. Journal of Reproductive Medicine 44(11): 933-938, 1999

3 day treatment with butoconazole nitrate for vulvovaginal candidiasis. Obstetrics & Gynecology 64(4): 530-534, 1984

Three-day treatment with butoconazole nitrate for vulvovaginal candidiasis. Obstetrics and Gynecology 64(4): 530-534, 1984

Effect of butoconazole nitrate 2% vaginal cream and miconazole nitrate 2% vaginal cream treatments in patients with vulvovaginal candidiasis. Infectious Diseases in Obstetrics and Gynecology 4(6): 323-328, 1996

An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis. Infectious Diseases in Obstetrics and Gynecology 13(4): 197-206, 2005

Three-day treatment of patients with vulvovaginal candidiasis: A comparison of butoconazole inserts with econazole ovules. Current Therapeutic Research 52(5): 729-740, 1992

Three-Day Combination Treatment for Vulvovaginal Candidosis with 200 mg Clotrimazol Vaginal Suppositories and Clotrimazol Cream for the Vulva is Significantly Better than Treatment with Vaginal Suppositories Alone - an Earlier, Multi-Centre, Placebo-Controlled Double Blind Study. Geburtshilfe und Frauenheilkunde 74(4): 355-360, 2014

Comparison of three-day butoconazole treatment with seven-day miconazole treatment for vulvovaginal candidiasis. Journal of Reproductive Medicine 34(7): 479-483, 1989

Butoconazole for vulvovaginal candidiasis. Medical Letter on Drugs and Therapeutics 28(717): 68-68, 1986

Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis. Diabetes Care 30(2): 312-317, 2007

Butoconazole nitrate in vulvovaginal candidiasis. A comparative study with clotrimazole. Ginecologia Y Obstetricia de Mexico 56: 138-143, 1988

Treatment of recurrent vulvo-vaginal candidiasis with sustained-released butoconazole pessary. Singapore Medical Journal 53(12): E269-E271, 2013